$175.58
4.062.37%
At close: -
$175.00
-0.58-0.33%
After Hours: 6:22 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for AbbVie (ABBV) was reported on October 30, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $2.94 to $2.98, compared to the estimated EPS of $2.95. Additionally, AbbVie forecasted revenue between $14.80B and $14.80B for the quarter.
Browse guidance and forecast on all stocks.